PAVmed Inc (NASDAQ: PAVM) shares more than quadrupled on Wednesday after the company’s subsidiary – Lucid Diagnostics – secured a major contract from the US government.According to PAVM’s press release, the US Department of Veterans Affairs (VA) has joined forces with Lucid to widen access to its EsoGuard Esophageal DNA…
The Senate’s push to set new rules for digital assets has hit a pause, with lawmakers redirecting attention to…
Global markets steadied on Thursday as investors reacted to a sharp easing of geopolitical tensions after US President Donald…
Goldman Sachs has revised its year-end 2026 gold price projection upwards, increasing the forecast to $5,400 per ounce from…
Eternal (ETEA.NS) shares rose on Thursday after its quick-commerce arm Blinkit broke even, a milestone that boosted investor confidence…
BitGo is poised to become the first cryptocurrency company to list in the United States this year after pricing…
China pushed back against US President Donald Trump’s criticism of its wind power record at the World Economic Forum…
Ubisoft Entertainment shares suffered their worst day on record on Thursday after the French video game publisher unveiled a…
Argentina’s economy is projected to grow 1.7% year-on-year in November, marking the second consecutive month of cooling activity following…
